S. 3193 · 118th Congress · Health

TREATS Act

Died in committee218 words Introduced Nov 1, 2023 · Latest action Nov 1, 2023

How far it has goneStopped at 2 of 6 · Died in committee
  1. IntroducedNov 1, 2023 Done
  2. CommitteeDied Jan 3, 2025 Stopped here
  3. Senate floorNot yet Not reached yet
  4. House floorNot yet Not reached yet
  5. Chambers agreeNot yet Not reached yet
  6. PresidentNot yet Not reached yet

Full text

No CRS summary yet · 218 words

S. 3193 · Introduced in Senate · Nov 1, 2023

SECTION 1. SHORT TITLE.

This Act may be cited as the Telehealth Response for E-prescribing Addiction Therapy Services Act or the TREATS Act .

SEC. 2. TELEHEALTH FOR SUBSTANCE USE DISORDER TREATMENT.

Section 309(e)(2) of the Controlled Substances Act ( 21 U.S.C. 829(e)(2) ) is amended— (1) in subparagraph (A)(i)— (A) by striking at least 1 in-person medical evaluation and inserting the following: at least— (I) 1 in-person medical evaluation ; and (B) by adding at the end the following: (II) for purposes of prescribing a controlled substance in schedule III, IV, or V that has been approved by the Food and Drug Administration for the treatment of a substance use disorder, 1 telehealth evaluation of the patient; or ; and (2) by adding at the end the following: (D) The term telehealth evaluation means a medical evaluation that is conducted in accordance with applicable Federal and State laws by a practitioner (other than a pharmacist) who is at a location remote from the patient and is communicating with the patient, or a practitioner who is treating the patient, using a telecommunications system referred to in section 1834(m) of the Social Security Act ( 42 U.S.C. 1395m(m) ) that includes audio-only or audio and video equipment permitting two-way, real-time interactive communication between the distant site practitioner and the patient, or the practitioner who is treating the patient. .

Shown here because the text is under 500 words. Open on Congress.gov

Who lobbies on it

4 organizations · 10 filings · Q4 2023–Q4 2024

One square per quarter since introduction, oldest left. Filled = named it that quarter.

  1. American Association of Nurse Practitioners 4 of 5 quarters
    “S. 260/H.R. 704 - Promoting Access to Diabetic Shoes Act H.R. 2583/S. 3481 - Increasing Access to Quality Cardiac Rehabilitation Care Act H.R. 2713/S. 2418 - Improving Care and Access to Nurses (ICAN) Act S. 3939/H.R. 7665 - ACO Assignment Improvement Act of 2024 H.R. 7266/S. 3770 - Future Advancement of Academic…”

    Q4 2024 filing · $1.6M lobbying spend in 2024, all issues

  2. Association for Behavioral Health and Wellness 4 of 5 quarters
    “-Expand access to medication assisted treatment -Drug Enforcement Agency (DEA) - rules for prescribing controlled medications via telemedicine. -SUPPORT Act -TREATS Act, H.R. 5361/S. 3193 -The Modernizing Opioid Treatment Access Act (MOTAA), (S. 644/H.R. 1359)”

    Q4 2024 filing · $264K lobbying spend in 2024, all issues

  3. Blue Cross Blue Shield of Michigan 1 of 5 quarters
    “Affordable Care Act (ACA), ACA subsidies and tax credits; Telehealth/ telehealth flexibilities; Mental Health Care; Youth Mental Health; Site neutral payment reform; hospital billing; Transparency in coverage; Surprise Billing; Prior Authorization; Hospital Consolidation; Health Equity Index reward factor…”

    Q4 2024 filing · $1.1M lobbying spend in 2024, all issues

1 more organization, every filingPROUpgrade

Organizations that named S. 3193 in a quarterly lobbying report. Covers organizations with a PAC on file; reports from organizations without one aren’t loaded yet. Spend is the organization’s total across all issues: reports don’t split spending by bill. Source: Senate lobbying disclosures (LD-2) from lda.gov; quotes are word for word from the “specific lobbying issues” field.

Actions

2 actions · newest first
  1. Nov 1, 2023Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
  2. Nov 1, 2023Introduced in Senate